{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:28:43Z","timestamp":1784132923805,"version":"3.55.0"},"reference-count":162,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Sj\u00f6gren\u2019s syndrome (SS) is a chronic systemic autoimmune disease that affects the salivary and lacrimal glands, as well as other organ systems like the lungs, kidneys and nervous system. SS can occur alone or in combination with another autoimmune disease, such as systemic lupus erythematosus (SLE) or rheumatoid arthritis. The etiology of SS is unknown but recent studies have revealed the implication of the activation of innate immune receptors, including Toll-like receptors (TLRs), mainly through the detection of endogenous nucleic acids, in the pathogenesis of systemic autoimmune diseases. Studies on SS mouse models suggest that TLRs and especially TLR7 that detects single-stranded RNA of microbial or endogenous origin can drive the development of SS and findings in SS patients corroborate those in mouse models. In this review, we will give an overview of the function and signaling of nucleic acid-sensing TLRs, the interplay of TLR7 with TLR8 and TLR9 in the context of autoimmunity, summarize the evidence for the critical role of TLR7 in the pathogenesis of SS and present a possible connection between SARS-CoV-2 and SS.<\/jats:p>","DOI":"10.3389\/fimmu.2022.980400","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T06:41:07Z","timestamp":1667198467000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Nucleic acid-sensing toll-like receptors: Important players in Sj\u00f6gren\u2019s syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Lena","family":"Alexopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-012513-104728","article-title":"Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Mavragani","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren\u2019s syndrome","volume":"2","author":"Brito-Zeron","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2014.01.001","article-title":"Sj\u00f6gren\u2019s syndrome: A forty-year scientific journey","volume":"51","author":"Moutsopoulos","year":"2014","journal-title":"J\u00a0Autoimmun"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00605-2","article-title":"Epithelial-immune cell interplay in primary Sj\u00f6gren\u2019s syndrome salivary gland pathogenesis","volume":"17","author":"Verstappen","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S47399","article-title":"The epidemiology of Sj\u00f6gren\u2019s syndrome","volume":"6","author":"Patel","year":"2014","journal-title":"Clin Epidemiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180392","article-title":"Primary versus secondary Sj\u00f6gren\u2019s syndrome: Is it time to reconsider these terms","volume":"46","author":"Mavragani","year":"2019","journal-title":"J Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-020117-043952","article-title":"Type I interferons in autoimmune disease","volume":"14","author":"Crow","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9093057","article-title":"Contributions of major cell populations to Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Witas","year":"2020","journal-title":"J Clin Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.278448","article-title":"Autoantibodies present before symptom onset in primary Sj\u00f6gren\u2019s syndrome","volume":"310","author":"Jonsson","year":"2013","journal-title":"JAMA"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/art.39214","article-title":"Prediction of Sj\u00f6gren\u2019s syndrome years before diagnosis and identification of patients with early onset and severe disease course by autoantibody profiling","volume":"67","author":"Theander","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.10.004","article-title":"Characteristics of the minor salivary gland infiltrates in Sj\u00f6gren\u2019s syndrome","volume":"34","author":"Christodoulou","year":"2010","journal-title":"J Autoimmun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2016.31.2.190","article-title":"The significance of ectopic germinal centers in the minor salivary gland of patients with Sj\u00f6gren\u2019s syndrome","volume":"31","author":"Lee","year":"2016","journal-title":"J Korean Med Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.625833","article-title":"Signaling through nucleic acid sensors and their roles in inflammatory diseases","volume":"11","author":"Okude","year":"2020","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/bs.ai.2016.11.001","article-title":"Nucleic acid immunity","volume":"133","author":"Hartmann","year":"2017","journal-title":"Adv Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030532","article-title":"Making sense of intracellular nucleic acid sensing in type I interferon activation in Sj\u00f6gren\u2019s syndrome","volume":"10","author":"Huijser","year":"2021","journal-title":"J Clin Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.929230","article-title":"Can the cGAS-STING pathway play a role in the dry eye","volume":"13","author":"Ouyang","year":"2022","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2021.09.006","article-title":"The Toll gene in Drosophila pattern formation","volume":"38","author":"Nusslein-Volhard","year":"2022","journal-title":"Trends Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.gene.6363937","article-title":"Toll-like receptors and their role in experimental models of microbial infection","volume":"4","author":"Qureshi","year":"2003","journal-title":"Genes Immun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/CS20140467","article-title":"Pound the alarm: Danger signals in rheumatic diseases","volume":"128","author":"O\u2019Reilly","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded rna and activation of NF-\u03baB by Toll-like receptor 3","volume":"413","author":"Alexopoulou","year":"2001","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/science.1093616","article-title":"Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA","volume":"303","author":"Diebold","year":"2004","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/science.1093620","article-title":"Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8","volume":"303","author":"Heil","year":"2004","journal-title":"Science"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0400937101","article-title":"Recognition of single-stranded RNA viruses by Toll-like receptor 7","volume":"101","author":"Lund","year":"2004","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/imr.12375","article-title":"Nucleic acid-sensing TLRs and autoimmunity: Novel insights from structural and cell biology","volume":"269","author":"Pelka","year":"2016","journal-title":"Immunol Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00577-0","article-title":"Regulation of the nucleic acid-sensing Toll-like receptors","volume":"22","author":"Lind","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.03.012","article-title":"Intracellular Toll-like receptors","volume":"32","author":"Blasius","year":"2010","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e28500","DOI":"10.1371\/journal.pone.0028500","article-title":"Unc93b1 physically associates with human TLR8 and regulates TLR8-mediated signaling","volume":"6","author":"Itoh","year":"2011","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nature06726","article-title":"Unc93b1 delivers nucleotide-sensing Toll-like receptors to endolysosomes","volume":"452","author":"Kim","year":"2008","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/science.1128346","article-title":"Herpes simplex virus encephalitis in human UNC-93b deficiency","volume":"314","author":"Casrouge","year":"2006","journal-title":"Science"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/ni1297","article-title":"The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9","volume":"7","author":"Tabeta","year":"2006","journal-title":"Nat Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.immuni.2018.04.011","article-title":"The chaperone Unc93b1 regulates Toll-like receptor stability independently of endosomal TLR transport","volume":"48","author":"Pelka","year":"2018","journal-title":"Immunity"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1014051107","article-title":"Slc15a4, ap-3, and hermansky-pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells","volume":"107","author":"Blasius","year":"2010","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/science.1187029","article-title":"Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3","volume":"329","author":"Sasai","year":"2010","journal-title":"Science"},{"key":"B37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/intimm\/dxy016","article-title":"Mechanisms controlling nucleic acid-sensing Toll-like receptors","volume":"30","author":"Miyake","year":"2018","journal-title":"Int Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41467-017-01687-x","article-title":"TLR7 mediated viral recognition results in focal type I interferon secretion by dendritic cells","volume":"8","author":"Saitoh","year":"2017","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nature03547","article-title":"Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction","volume":"434","author":"Honda","year":"2005","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/ITT.S89795","article-title":"Toll-like receptors in the pathogenesis of autoimmune diseases: Recent and emerging translational developments","volume":"5","author":"Duffy","year":"2016","journal-title":"Immunotargets Ther"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.76.060305.151318","article-title":"Structure and function of toll receptors and their ligands","volume":"76","author":"Gay","year":"2007","journal-title":"Annu Rev Biochem"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.07.013","article-title":"Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus","volume":"25","author":"Christensen","year":"2006","journal-title":"Immunity"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.2.1349","article-title":"Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus","volume":"177","author":"Lartigue","year":"2006","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/art.21553","article-title":"Toll-like receptor 9 signaling protects against murine lupus","volume":"54","author":"Wu","year":"2006","journal-title":"Arthritis rheumatism"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxl067","article-title":"Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE","volume":"18","author":"Yu","year":"2006","journal-title":"Int Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.09.009","article-title":"Control of Toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation","volume":"27","author":"Deane","year":"2007","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838138","article-title":"Yaa autoimmune phenotypes are conferred by overexpression of TLR7","volume":"38","author":"Fairhurst","year":"2008","journal-title":"Eur J Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902592","article-title":"TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus","volume":"184","author":"Nickerson","year":"2010","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.11.001","article-title":"Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice","volume":"34","author":"Santiago-Raber","year":"2010","journal-title":"J Autoimmun"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1314121111","article-title":"TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL\/6 mice","volume":"111","author":"Desnues","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M605311200","article-title":"The functional effects of physical interactions among Toll-like receptors 7, 8, and 9","volume":"281","author":"Wang","year":"2006","journal-title":"J Biol Chem"},{"key":"B52","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1051\/medsci\/2012281023","article-title":"Toll-like receptor 8: The awkward TLR","volume":"28","author":"Alexopoulou","year":"2012","journal-title":"Med Sci (Paris)"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2009.11.003","article-title":"A five-Amino-Acid motif in the undefined region of the TLR8 ectodomain is required for species-specific ligand recognition","volume":"47","author":"Liu","year":"2010","journal-title":"Mol Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI42081","article-title":"TLR8 deficiency leads to autoimmunity in mice","volume":"120","author":"Demaria","year":"2010","journal-title":"J Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/imm.12426","article-title":"Toll-like receptor 8 deletion accelerates autoimmunity in a mouse model of lupus through a Toll-like receptor 7-dependent mechanism","volume":"145","author":"Tran","year":"2015","journal-title":"Immunology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131044","article-title":"RNA recognition by human TLR8 can lead to autoimmune inflammation","volume":"210","author":"Guiducci","year":"2013","journal-title":"J Exp Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26452","article-title":"TLR8\/TLR7 dysregulation due to a novel TLR8 mutation causes severe autoimmune hemolytic anemia and autoinflammation in identical twins","volume":"97","author":"Fejtkova","year":"2022","journal-title":"Am J Hematol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1172\/JCI132328","article-title":"B cell-intrinsic TLR9 expression is protective in murine lupus","volume":"130","author":"Tilstra","year":"2020","journal-title":"J Clin Invest"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082316","article-title":"Unc93b1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing","volume":"206","author":"Fukui","year":"2009","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.immuni.2011.05.010","article-title":"Unc93b1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking","volume":"35","author":"Fukui","year":"2011","journal-title":"Immunity"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.2174\/1381612821666150316120024","article-title":"Mouse models of primary Sj\u00f6gren\u2019s syndrome","volume":"21","author":"Park","year":"2015","journal-title":"Curr Pharm Des"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1246818","article-title":"Current and emerging evidence for Toll-like receptor activation in Sj\u00f6gren\u2019s syndrome","volume":"2018","author":"Kiripolsky","year":"2018","journal-title":"J Immunol Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063090","article-title":"Role of the innate immunity signaling pathway in the pathogenesis of Sj\u00f6gren\u2019s syndrome","volume":"22","author":"Shimizu","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2337\/db18-0331","article-title":"Type I and ii interferon receptors differentially regulate type 1 diabetes susceptibility in male versus female nod mice","volume":"67","author":"Carrero","year":"2018","journal-title":"Diabetes"},{"key":"B65","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1016\/j.celrep.2019.11.010","article-title":"Interleukin-27 is essential for type 1 diabetes development and Sj\u00f6gren\u2019s syndrome-like inflammation","volume":"29","author":"Ciecko","year":"2019","journal-title":"Cell Rep"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12439","article-title":"Reversible lacrimal gland-protective regulatory T-cell dysfunction underlies male-specific autoimmune dacryoadenitis in the non-obese diabetic mouse model of Sj\u00f6gren\u2019s syndrome","volume":"145","author":"Lieberman","year":"2015","journal-title":"Immunology"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502465","article-title":"Cutting edge: Commensal microbiota has disparate effects on manifestations of polyglandular autoimmune inflammation","volume":"197","author":"Hansen","year":"2016","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1000702","article-title":"Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines","volume":"186","author":"Kuznik","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0714.2012.01136.x","article-title":"Involvement of Toll-like receptors in autoimmune sialoadenitis of the non-obese diabetic mouse","volume":"41","author":"Shimizu","year":"2012","journal-title":"J Oral Pathol Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"14272","DOI":"10.1038\/s41598-018-32690-x","article-title":"MyD88 signaling causes autoimmune sialadenitis through formation of high endothelial venules and upregulation of LT\u03b2 receptor-mediated signaling","volume":"8","author":"Into","year":"2018","journal-title":"Sci Rep"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.job.2021.04.003","article-title":"Effect of MyD88 deficiency on gene expression profiling in salivary glands of female non-obese diabetic (NOD) mice","volume":"63","author":"Mori","year":"2021","journal-title":"J Oral Biosci"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028727","article-title":"Activation of the alternative NF\u03baB pathway improves disease symptoms in a model of Sj\u00f6gren\u2019s syndrome","volume":"6","author":"Gilboa-Geffen","year":"2011","journal-title":"PloS One"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/jop.12209","article-title":"Activation of TLR9-dependent p38MAPK pathway in the pathogenesis of primary Sj\u00f6gren\u2019s syndrome in NOD\/Ltj mouse","volume":"43","author":"Shi","year":"2014","journal-title":"J Oral Pathol Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249478","article-title":"Toll-like receptor 7 is required for lacrimal gland autoimmunity and type 1 diabetes development in male nonobese diabetic mice","volume":"21","author":"Debreceni","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1126\/science.1233521","article-title":"Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity","volume":"339","author":"Markle","year":"2013","journal-title":"Science"},{"key":"B76","doi-asserted-by":"publisher","first-page":"17969","DOI":"10.1038\/s41598-019-54410-9","article-title":"Hyperglycemia and salivary gland dysfunction in the non-obese diabetic mouse: Caveats for preclinical studies in Sj\u00f6gren\u2019s syndrome","volume":"9","author":"Allushi","year":"2019","journal-title":"Sci Rep"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/art.10258","article-title":"Two NOD idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sj\u00f6gren\u2019s syndrome) on a healthy murine background","volume":"46","author":"Cha","year":"2002","journal-title":"Arthritis rheumatism"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.3700487","article-title":"Early pathogenic events associated with Sj\u00f6gren\u2019s syndrome (Sjs)-like disease of the NOD mouse using microarray analysis","volume":"86","author":"Killedar","year":"2006","journal-title":"Lab Invest"},{"key":"B79","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1084\/jem.176.1.67","article-title":"Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. the NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes","volume":"176","author":"Wicker","year":"1992","journal-title":"J Exp Med"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2017.04.009","article-title":"Systemic manifestations of primary Sj\u00f6gren\u2019s syndrome in the NOD.B10sn-H2(B)\/J mouse model","volume":"183","author":"Kiripolsky","year":"2017","journal-title":"Clin Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T","article-title":"A novel NOD-derived murine model of primary Sj\u00f6gren\u2019s syndrome","volume":"41","author":"Robinson","year":"1998","journal-title":"Arthritis rheumatism"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.3A0717-311R","article-title":"MyD88 is required for disease development in a primary Sj\u00f6gren\u2019s syndrome mouse model","volume":"102","author":"Kiripolsky","year":"2017","journal-title":"J Leukoc Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02963","article-title":"Activation of MyD88-dependent TLRs mediates local and systemic inflammation in a mouse model of primary Sj\u00f6gren\u2019s syndrome","volume":"10","author":"Kiripolsky","year":"2019","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.692216","article-title":"Immune-intrinsic MyD88 directs the production of antibodies with specificity for extracellular matrix components in primary Sj\u00f6gren\u2019s syndrome","volume":"12","author":"Kiripolsky","year":"2021","journal-title":"Front Immunol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/OARRR.S167783","article-title":"Sj\u00f6gren\u2019s syndrome and systemic lupus erythematosus: Links and risks","volume":"11","author":"Pasoto","year":"2019","journal-title":"Open Access Rheumatol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2014.883920","article-title":"The value of animal models to study immunopathology of primary human Sj\u00f6gren\u2019s syndrome symptoms","volume":"10","author":"Donate","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13075-015-0798-8","article-title":"Low-intensity pulsed ultrasound rescues insufficient salivary secretion in autoimmune sialadenitis","volume":"17","author":"Sato","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/art.22571","article-title":"Protection against autoimmune nephritis in MyD88-deficient MRL\/Lpr mice","volume":"56","author":"Sadanaga","year":"2007","journal-title":"Arthritis rheumatism"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02015","article-title":"Lupus autoimmunity and metabolic parameters are exacerbated upon high fat diet-induced obesity due to TLR7 signaling","volume":"10","author":"Hanna Kazazian","year":"2019","journal-title":"Front Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.676010","article-title":"TLR7 signaling drives the development of Sj\u00f6gren\u2019s syndrome","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"B91","doi-asserted-by":"crossref","unstructured":"Hanna KazazianN\n          FranceAix-Mareseille UniversityLupus autoimmunity and metabolic parameters are exacerbated upon high fat diet-induced obesity due to TLR7 signaling2019","DOI":"10.3389\/fimmu.2019.02015"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12520","article-title":"Expression of Toll-like receptors in peripheral blood mononuclear cells of patients with primary Sj\u00f6gren\u2019s syndrome","volume":"85","author":"Karlsen","year":"2017","journal-title":"Scandinavian J Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.tripleo.2010.01.006","article-title":"Expression of Toll-like receptors 7, 8, and 9 in primary Sj\u00f6gren\u2019s syndrome","volume":"109","author":"Zheng","year":"2010","journal-title":"Oral surg Oral med Oral pathol Oral radiol endodontics"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209589","article-title":"Contrasting expression pattern of RNA-sensing receptors TLR7, rig-I and Mda5 in interferon-positive and interferon-negative patients with primary Sj\u00f6gren\u2019s syndrome","volume":"76","author":"Maria","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B95","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/cei.13242","article-title":"Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sj\u00f6gren\u2019s syndrome patients","volume":"196","author":"Shimizu","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e0120383","DOI":"10.1371\/journal.pone.0120383","article-title":"Expression of Toll-like receptor -7 and -9 in b cell subsets from patients with primary Sj\u00f6gren\u2019s syndrome","volume":"10","author":"Karlsen","year":"2015","journal-title":"PloS One"},{"key":"B97","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s12026-014-8523-2","article-title":"Toll-like receptors and B cells: Functions and mechanisms","volume":"59","author":"Buchta","year":"2014","journal-title":"Immunol Res"},{"key":"B98","doi-asserted-by":"publisher","first-page":"e12662","DOI":"10.1111\/sji.12662","article-title":"Transcription profiling of peripheral B cells in antibody-positive primary Sj\u00f6gren\u2019s syndrome reveals upregulated expression of Cx3cr1 and a type I and type II interferon signature","volume":"87","author":"Imgenberg-Kreuz","year":"2018","journal-title":"Scandinavian J Immunol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12368","article-title":"TLR-7 and -9 stimulation of peripheral blood B cells indicate altered TLR signalling in primary Sj\u00f6gren\u2019s syndrome patients by increased secretion of cytokines","volume":"82","author":"Karlsen","year":"2015","journal-title":"Scandinavian J Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-3-662-43492-5_4","article-title":"Interleukin-10-Producing B cells and the regulation of immunity","volume":"380","author":"Hilgenberg","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00281","article-title":"Single cell based phosphorylation profiling identifies alterations in Toll-like receptor 7 and 9 signaling in patients with primary Sj\u00f6gren\u2019s syndrome","volume":"10","author":"Davies","year":"2019","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00138","article-title":"Clinical characteristics of secondary immune thrombocytopenia associated with primary Sj\u00f6gren\u2019s syndrome","volume":"7","author":"Dai","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13464","article-title":"Ten-year observation of patients with primary Sj\u00f6gren\u2019s syndrome: Initial presenting characteristics and the associated outcomes","volume":"22","author":"Tsukamoto","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.637659","article-title":"Activation of Toll-like receptor 7 signaling pathway in primary Sj\u00f6gren\u2019s syndrome-associated thrombocytopenia","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B105","article-title":"Role of production of type I interferons by B cells in the mechanisms and pathogenesis of systemic lupus erythematosus","volume":"25","author":"Hamilton","year":"2018","journal-title":"Discovery Med"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/art.39795","article-title":"Expression of long interspersed nuclear element 1 retroelements and induction of type I interferon in patients with systemic autoimmune disease","volume":"68","author":"Mavragani","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131093","article-title":"Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors","volume":"5","author":"Dembny","year":"2020","journal-title":"JCI Insight"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2872","article-title":"The enemy within: Endogenous retroelements and autoimmune disease","volume":"15","author":"Volkman","year":"2014","journal-title":"Nat Immunol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/BOR.0000000000000564","article-title":"Sex bias in autoimmunity","volume":"31","author":"Billi","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/bs.ai.2019.04.001","article-title":"Deconstructing the sex bias in allergy and autoimmunity: From sex hormones and beyond","volume":"142","author":"Laffont","year":"2019","journal-title":"Adv Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/nature03479","article-title":"X-Inactivation profile reveals extensive variability in X-linked gene expression in females","volume":"434","author":"Carrel","year":"2005","journal-title":"Nature"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/art.39560","article-title":"X Chromosome dose and sex bias in autoimmune diseases: Increased prevalence of 47,XXX in systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome","volume":"68","author":"Liu","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2016.04.002","article-title":"Klinefelter\u2019s syndrome (47,XXY) is in excess among men with Sj\u00f6gren\u2019s syndrome","volume":"168","author":"Harris","year":"2016","journal-title":"Clin Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1002\/art.40207","article-title":"Rare X chromosome abnormalities in systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome","volume":"69","author":"Sharma","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108485","article-title":"Heterogeneous escape from X chromosome inactivation results in sex differences in type I IFN responses at the single human pDC level","volume":"33","author":"Hagen","year":"2020","journal-title":"Cell Rep"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-018-0712-y","article-title":"Female predisposition to TLR7-driven autoimmunity: Gene dosage and the escape from X chromosome inactivation","volume":"41","author":"Souyris","year":"2019","journal-title":"Semin Immunopathol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2004","article-title":"Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1","volume":"15","author":"Meier","year":"2009","journal-title":"Nat Med"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-371831","article-title":"The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor \u03b1 signaling","volume":"119","author":"Seillet","year":"2012","journal-title":"Blood"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201646725","article-title":"Human pDCs display sex-specific differences in type I interferon subtypes and interferon \u03b1\/\u03b2 receptor expression","volume":"47","author":"Ziegler","year":"2017","journal-title":"Eur J Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13032","article-title":"Environmental factors in the pathogenesis of primary Sj\u00f6gren\u2019s syndrome","volume":"287","author":"Bjork","year":"2020","journal-title":"J Intern Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.608728","article-title":"The impact of SARS-CoV-2 outbreak on primary Sj\u00f6gren\u2019s syndrome: An Italian experience","volume":"7","author":"Carubbi","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000776","article-title":"COVID-19 and autoimmune diseases","volume":"33","author":"Liu","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8101468","article-title":"SARS-CoV-2: From structure to pathology, host immune response and therapeutic management","volume":"8","author":"Mihaescu","year":"2020","journal-title":"Microorganisms"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00522-1","article-title":"The first 12 months of COVID-19: A timeline of immunological insights","volume":"21","author":"Carvalho","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41591-021-01296-8","article-title":"SARS-CoV-2 infection of the oral cavity and saliva","volume":"27","author":"Huang","year":"2021","journal-title":"Nat Med"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26045","article-title":"Systematic analysis of Ace2 and Tmprss2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2","volume":"92","author":"Song","year":"2020","journal-title":"J Med Virol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1002\/path.5679","article-title":"Salivary glands are a target for SARS-CoV-2: A source for saliva contamination","volume":"254","author":"Matuck","year":"2021","journal-title":"J Pathol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1111\/odi.13925","article-title":"Increase in the number of Sj\u00f6gren\u2019s syndrome cases in Brazil in the COVID-19 era","author":"Martelli Junior","year":"2021","journal-title":"Oral Dis"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl4348","article-title":"X-Linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19","volume":"6","author":"Asano","year":"2021","journal-title":"Sci Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021109622","article-title":"TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection","volume":"41","author":"van der Sluis","year":"2022","journal-title":"EMBO J"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.67569","article-title":"Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study","volume":"10","author":"Fallerini","year":"2021","journal-title":"eLife"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.13719","article-title":"Presence of genetic variants among young men with severe COVID-19","volume":"324","author":"van der Made","year":"2020","journal-title":"JAMA"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03631-y","article-title":"Diverse functional autoantibodies in patients with COVID-19","volume":"595","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05359-y","article-title":"High levels of anti-SSA\/Ro antibodies in COVID-19 patients with severe respiratory failure: A case-based review: High levels of anti-SSA\/Ro antibodies in COVID-19","volume":"39","author":"Fujii","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS-STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04421-w","article-title":"The cGAS-STING pathway drives type I IFN immunopathology in COVID-19","volume":"603","author":"Domizio","year":"2022","journal-title":"Nature"},{"key":"B137","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s42003-021-02983-5","article-title":"SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-\u03baB","volume":"5","author":"Neufeldt","year":"2022","journal-title":"Commun Biol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.756315","article-title":"Toll-like receptors as a therapeutic target in the era of immunotherapies","volume":"9","author":"Farooq","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2017.00508","article-title":"Inhibition of Toll-like receptor signaling as a promising therapy for inflammatory diseases: A journey from molecular to nano therapeutics","volume":"8","author":"Gao","year":"2017","journal-title":"Front Physiol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.2174\/1381612826666200707132920","article-title":"The role of chloroquine and hydroxychloroquine in immune regulation and diseases","volume":"26","author":"Martinez","year":"2020","journal-title":"Curr Pharm Des"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.7682","article-title":"Effects of hydroxychloroquine on symptomatic improvement in primary Sj\u00f6gren\u2019s syndrome: The JOQUER randomized clinical trial","volume":"312","author":"Gottenberg","year":"2014","journal-title":"JAMA"},{"key":"B142","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1124\/jpet.120.000275","article-title":"Discovery of M5049: A novel selective Toll-like receptor 7\/8 inhibitor for treatment of autoimmunity","volume":"376","author":"Vlach","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"key":"B143","doi-asserted-by":"publisher","first-page":"e00842","DOI":"10.1002\/prp2.842","article-title":"Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of Toll-like receptors 7 and 8","volume":"9","author":"Port","year":"2021","journal-title":"Pharmacol Res Perspect"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737815","article-title":"Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms","volume":"37","author":"Barrat","year":"2007","journal-title":"Eur J Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006101162","article-title":"Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus","volume":"18","author":"Pawar","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.57","article-title":"A Toll-like receptor 7, 8, and 9 antagonist inhibits Th1 and Th17 responses and inflammasome activation in a model of IL-23-Induced psoriasis","volume":"133","author":"Jiang","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt078","article-title":"Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9","volume":"41","author":"Kandimalla","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2013.798651","article-title":"A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW\/F1 mice","volume":"46","author":"Zhu","year":"2013","journal-title":"Autoimmunity"},{"key":"B149","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.clim.2016.09.015","article-title":"IMO-8400, a Toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-Severe plaque psoriasis","volume":"174","author":"Balak","year":"2017","journal-title":"Clin Immunol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1158\/1538-7445.AM2014-2570","article-title":"IMO-8400, a selective antagonist of TLRs 7, 8 and 9, inhibits MyD88 L265P mutation-driven signaling and cell survival: A potential novel approach for treatment of b-cell lymphomas harboring MyD88 L265P mutation","volume":"74","author":"Bhagat","year":"2014","journal-title":"Cancer Res"},{"key":"B151","first-page":"1769","article-title":"Bms-986256, an oral novel Toll-like receptor 7 and 8 (TLR7\/8) inhibitor, does not affect the pharmacokinetics of mycophenolate mofetil in healthy subjects","author":"Chiney","year":"2021","journal-title":"Arthritis Rheum"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1002\/art.41966","article-title":"First-in-Human safety, pharmacokinetic and pharmacodynamic study of escalating single- and multiple-doses of bms-986256, a novel, potent, oral inhibitor of TLR7 and TLR8","volume":"73","author":"Harrison","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2016.31.7.1127","article-title":"Effect of hydroxychloroquine treatment on dry eyes in subjects with primary Sj\u00f6gren\u2019s syndrome: A double-blind randomized control study","volume":"31","author":"Yoon","year":"2016","journal-title":"J Korean Med Sci"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20101048","article-title":"Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9","volume":"207","author":"Guiducci","year":"2010","journal-title":"J Exp Med"},{"key":"B155","doi-asserted-by":"publisher","first-page":"e84634","DOI":"10.1371\/journal.pone.0084634","article-title":"Suppression of molecular inflammatory pathways by Toll-like receptor 7, 8, and 9 antagonists in a model of IL-23-Induced skin inflammation","volume":"8","author":"Suarez-Farinas","year":"2013","journal-title":"PloS One"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300706","article-title":"Guanine modification of inhibitory oligonucleotides potentiates their suppressive function","volume":"191","author":"Rommler","year":"2013","journal-title":"J Immunol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116703","article-title":"Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells","volume":"10","author":"Rommler","year":"2015","journal-title":"PloS One"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.0c00264","article-title":"Discovery of potent and orally bioavailable small molecule antagonists of Toll-like receptors 7\/8\/9 (TLR7\/8\/9)","volume":"11","author":"Mussari","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.777197","article-title":"Anti-TLR7 antibody protects against lupus nephritis in NZBWF1 mice by targeting B cells and patrolling monocytes","volume":"12","author":"Murakami","year":"2021","journal-title":"Front Immunol"},{"key":"B160","article-title":"Type I interferon signature in Sj\u00f6gren\u2019s syndrome: Pathophysiological and clinical implications","author":"Marketos","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jid.2021.11.031","article-title":"Type I interferons in autoimmunity","volume":"142","author":"Fernandez-Ruiz","year":"2022","journal-title":"J\u00a0Invest Dermatol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: From bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct Target Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.980400\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T06:41:13Z","timestamp":1667198473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.980400\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":162,"alternative-id":["10.3389\/fimmu.2022.980400"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.980400","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"article-number":"980400"}}